lestaurtinib has been researched along with Seizures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allam, J; Atoui, Z; Bashir, B; Darwish, H; Darwish, N; Hamade, E; Karnib, N; Kobeissy, F; Medlej, Y; Obeid, M; Saad, S; Salah, H; Wadi, L; Wang, KKW | 1 |
| Jensen, FE; Klein, PM; Obeid, M; Rosenberg, EC | 1 |
2 other study(ies) available for lestaurtinib and Seizures
| Article | Year |
|---|---|
Lestaurtinib (CEP-701) modulates the effects of early life hypoxic seizures on cognitive and emotional behaviors in immature rats.
Topics: Animals; Animals, Newborn; Carbazoles; Cognition; Emotions; Furans; Hypoxia; Male; Maze Learning; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Seizures | 2019 |
Lestaurtinib (CEP-701) attenuates "second hit" kainic acid-induced seizures following early life hypoxic seizures.
Topics: Animals; Anticonvulsants; Carbazoles; Furans; Hippocampus; Hypoxia; Kainic Acid; Male; Phosphorylation; Rats; Rats, Long-Evans; Receptor, trkB; Seizures | 2014 |